![](/images/statetntennesseelibraries/default-album/untitled-(1200-400-px)-(2000-667-px).png?sfvrsn=227716e8_1)
MATE Act Resources
The Medication Access and Training Expansion (MATE) Act creates a new one-time training requirement for any provider who is applying for or renewing their Drug Enforcement Administration (DEA) registration. As of June 27, 2023, DEA-registered practitioners are required to check a box affirming they have completed the new training requirement when renewing.
This is a one-time training requirement, according to the DEA. The 8 hours of training can occur in multiple sessions that equal 8 hours of training. Past courses can count toward fulfilling this requirement if they are a DEA-approved: topic, medium and provider. The training must be provided by one of the groups approved by the DEA. Dentists should keep a record of the 8 hours of opioid and substance use disorder training they complete for this requirement.
To assist members, the ADA has published a Frequently Asked Questions document to address common questions. It includes links to courses that fulfill this requirement and are free to members and information on additional approved providers. Members are urged to review the FAQ document and contact ADA Member Service Center via email at msc@ada.org or call 312-440-2500 with additional questions or concerns. MSC staff are available Monday through Friday from 8 a.m.- 5 p.m. CT.
Note: The requirement does not apply to dentists that graduated from dental school within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training.
Training Opportunities
Emergency Department Referral Model in Action 1 Hour | Recorded Webinar no cost Members / no cost non-members
Presented by:
![ADA ADA](https://www.njda.org/images/librariesprovider35/default-album/ada.tmb-thumb160.jpg?sfvrsn=24ecbb8a_1)
REGISTRATION
Course Overview
The high frequency of utilization of the hospital ED by patients seeking care for non-emergent dental conditions provided the impetus for Mercy Health, Ohio’s largest healthcare provider, to develop strategic approaches to pain management and the opioid crisis by creating a definitive care concept, an evidence-based pain management curriculum, a substance abuse screening tool, and strategic utilization of the electronic medical record to track inappropriate prescribing profiles to alert and educate prescribers relative to best practices.
After completing this courses, participants will be able to:
- Understand the development, operational approach and rationale for implementing the Definitive Care Concept
- Recognize evidence-based approaches to pain management including preoperative, perioperative, and postoperative approaches
- Recognize the benefits of creating tools to improve identification of at-risk patients, encourage early treatment referrals, establish acute withdrawal protocols and provide more efficient access to available PDMP databases
Presented by the ADA Council on Advocacy for Access & Prevention and M. Frank Beck, DDS, FAAHD, MAGD, FICOI, DSCDA
Clinical Practice Guideline for Management of Acute Dental Pain 1 Hour | Recorded Webinar no cost Members / no cost non-members
Overview
This course educates dental providers on the new evidence-based clinical practice guideline (CPG) for the management of acute dental pain. The CPG was developed as part of the FDA funded research project titled, "Evidence-based Clinical Practice Guideline for the Management of Acute Dental Pain: Development, Implementation, and Evaluation Using Data Analytics to Target An Implementation Strategy." The project is a collaboration between the ADA Science & Research Institute, the University of Pittsburgh, and the University of Pennsylvania.
Presenters
Deborah Polk, PhD, Assistant Professor, University of Pittsburgh
Paul A. Moore, DMD, PhD, MPH, Professor emeritus, University of Pittsburgh
Learning Objectives
After completing this course, you should be able to:
• State the benefits of NSAIDs over opioids
• List examples of recommendations from the clinical practice guideline for the management of acute dental pain
• Use communication skills with patients
• Incorporate patient responses into and develop a plan for a patient’s pain management
• Begin to incorporate the guideline into practice
The Special Considerations of Pain Management and Opioid Use in Older Adults 1 Hour | Recorded Webinar no cost Members / no cost non-members
![ADA ADA](https://www.njda.org/images/librariesprovider35/default-album/ada.tmb-thumb160.jpg?sfvrsn=24ecbb8a_1)
REGISTRATION
Many older people have a variety of systemic diseases that have an impact on their oral health care. Analgesic medications may be part of a patient’s comprehensive treatment plan for relieving pain.
Pain management in older, medically complex patients requires special considerations. As physiologic, cognitive, and social factors change, so does the approach to patient centered management of oral healthcare. Dentists prescribing opioids for pain management has evolved but increased awareness to identify misuse, specifically by older adults is needed.
Upon completion of the archived webinar participants will:
- Describe special considerations for treating older adults, assessing their pain and interpreting their health status.
- Review risk factors for opioid toxicity in older adults.
- Review opioid misuse in older adult population.
Opioids, Dentistry and Addiction: The Dentist's Role in Treating Pain 1 Hour | Recorded Webinar no cost Members / no cost non-members
![ADA ADA](https://www.njda.org/images/librariesprovider35/default-album/ada.tmb-thumb160.jpg?sfvrsn=24ecbb8a_1)
REGISTRATION
Drs. Sharon Parsons and David Kimberly presented a one hour webinar on October 21, 2021 that covered the important topic of Opioids, Dentistry and Addiction: The Dentist’s Role in Treating Pain. The United States experienced a tragic rise in drug overdose deaths in 2020, which was largely caused by inappropriate use of opioids. Viewers will hear from a practicing dentist and an oral surgeon about the positive role dentists can play to help mitigate the opioid crisis. Additionally, viewers will gain a better understanding about substance use and addiction as well as learn about the best options currently available for the treatment of acute pain.
The Impact of COVID-19 on the Addiction Field: A Call to Dentists 1 Hour | Recorded Webinar no cost Members / no cost non-members
![ADA ADA](https://www.njda.org/images/librariesprovider35/default-album/ada.tmb-thumb160.jpg?sfvrsn=24ecbb8a_1)
REGISTRATION
Wilson Compton, M.D., M.P.E. is a nationally known expert on the causes and prevention of drug abuse and is the Deputy Director, National Institute on Drug Abuse (NIDA). During this on-demand webinar, recorded November 10, 2021, he will present a comprehensive overview of the state of the opioid crisis amidst the COVID-19 pandemic and the various initiatives at the National Institutes of Health (NIH) to combat that crisis as well as COVID-19. Dr. Compton’s presentation will include a review of multiple NIH collaborative efforts to address interdisciplinary challenges associated with the pandemic and the “Helping to End Addiction Long-Term (HEAL) Initiative:” a trans-agency effort to speed scientific solutions to curb the opioid public health crisis. Additionally, he will summarize the science and tools available to dentists as they are addressing substance use issues in their clinical practices.
Viewers of this webinar will be able to:
- Identify novel treatments for substance use disorders and drug-involved overdose
- Review implementation science with the goal to improve the uptake and delivery of evidence-based care
- Discuss ways to talk to patients appropriately about substance use while avoiding stigma
- Review current screening tools such as the "Words Matter'' CE activities and the NIDAMED web portal
Integrating Controlled Substance Risk Assessment and Management into Dental Practice 1 Hour | Recorded Webinar no cost Members / no cost non-members
![ADA ADA](https://www.njda.org/images/librariesprovider35/default-album/ada.tmb-thumb160.jpg?sfvrsn=24ecbb8a_1)
REGISTRATION
This on-demand webinar from July 21, 2021 will cover evidence-based strategies for integrating controlled substance risk assessment into the dental practice. These strategies include: a review of the prevalence of substance misuse and abuse among dental patients, reducing risk by brief structured assessment, recognizing comorbid patient risk factors, usage of state prescription drug monitoring programs, and inter-professional collaboration with colleagues in addiction medicine/mental health, primary care, and pain medicine.
Viewers will learn strategies for delegating aspects of assessment and management to dental hygienists and other supervised clinicians. Barriers to implementation will also be discussed. The above template for care is based upon current work in development through the Tufts Controlled Substance Risk Mitigation Project.
Upon viewing this webinar, you will be able to:
- Recognize patient risk factors for misuse and abuse of controlled substances
- Review tools for assessing patient risk, including validated screeners and state prescription drug monitoring program databases
- Identify strategies for improved inter-professional care of complex patients with active substance use disorder
Pharmacological Approaches to Dental Pain Management: Navigating Substance Use Risk 2 Hours | Recorded Webinar no cost Members / no cost non-members
Registration
MATE Act FAQs
How will practitioners be asked to report satisfying this new training requirement?
Beginning on June 27, 2023, practitioners will be required to check a box on their online DEA registration form.
What is the deadline for satisfying this new training requirement?
The deadline is the date of a practitioner’s next scheduled DEA registration submission.
How can practitioners satisfy this new training requirement?
Practitioners can satisfy this training by engaging in a total of eight hours of training on treatment and management of patients with opioid or other substance use disorders utilizing a DEA-approved medium AND provider.
Do courses I have taken to satisfy Tennessee licensing requirements on chemical dependency and prescription-writing count?
It depends. While the topic may be satisfied, you should ensure that the course was provided by an approved provider. The ADA, the American Association of Oral and Maxillofacial Surgeons (AAOMS), and ADA CERP providers are designated dental training providers. A complete list of approved providers including non-dental organizations is listed in the ADA Frequently Asked Questions on page 5-6.
Does CE taken at TDA component society meetings count?
No, TDA component societies are not CERP providers. Additionally, some major dental meetings are PACE providers, not CERP. Please check your proof of attendance/CE certificates closely. If the course was given by a CERP Provider, it will have the CERP logo on it.
Does the self-study course on chemical dependency and prescription-writing in the TDA Journal count?
There is a question of whether journal articles will count toward this requirement. We have asked for clarification, but the DEA may not clarify this issue.
Will the DEA accept TDA ACE report is a record of my training?
At this time, the DEA has not indicated how or if they plan to audit compliance. ACE reports are a convenience for member-tracking as it relates to state licensure. They are not meant to be documentation of fulfillment of requirements.
I want to take training to make sure I am covered. What do you suggest?
ADA Frequently Asked Questions lists eight (8) one-hour online courses provided by the TDA that are free to members. You will find the course list on page 4-5.
I have other questions. How can I get answers to my questions?
The ADA has published a Frequently Asked Questions document to address these and other common questions. You can also contact ADA Member Service Center via email at msc@ada.org or call 312-440-2500 with additional questions or concerns. MSC staff are available Monday through Friday from 8 a.m. - 5 p.m. CT.
For official answers from the DEA, please email your questions to the Diversion Control Division Policy Section at ODLP@dea.gov, or call 571-362-3260.